Contribution of Coagulases towards Disease and Protective Immunity
The bacterial pathogen Staphylococcus aureus seeds abscesses in host tissues to replicate at the center of these lesions, protected from host immune cells via a pseudocapsule. Using histochemical staining, we identified prothrombin and fibrin within abscesses and pseudocapsules. S. aureus secretes two clotting factors, coagulase (Coa) and von Willebrand factor binding protein (vWbp). We report here that Coa and vWbp together are required for the formation of abscesses. Coa and vWbp promote the non-proteolytic activation of prothrombin and cleavage of fibrinogen, reactions that are inhibited with specific antibody against each of these molecules. Coa and vWbp specific antibodies confer protection against abscess formation and S. aureus lethal bacteremia, suggesting that coagulases function as protective antigens for a staphylococcal vaccine.
Vyšlo v časopise:
Contribution of Coagulases towards Disease and Protective Immunity. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001036
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001036
Souhrn
The bacterial pathogen Staphylococcus aureus seeds abscesses in host tissues to replicate at the center of these lesions, protected from host immune cells via a pseudocapsule. Using histochemical staining, we identified prothrombin and fibrin within abscesses and pseudocapsules. S. aureus secretes two clotting factors, coagulase (Coa) and von Willebrand factor binding protein (vWbp). We report here that Coa and vWbp together are required for the formation of abscesses. Coa and vWbp promote the non-proteolytic activation of prothrombin and cleavage of fibrinogen, reactions that are inhibited with specific antibody against each of these molecules. Coa and vWbp specific antibodies confer protection against abscess formation and S. aureus lethal bacteremia, suggesting that coagulases function as protective antigens for a staphylococcal vaccine.
Zdroje
1. LowyFD
1998 Staphylococcus aureus infections. New Engl J Med 339 520 532
2. KlevensRM
EdwardsJR
GaynesRP
SystemNNIS
2008 The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis 47 927 930
3. RogersDE
MellyMA
1965 Speculation on the immunology of Mudd, S. Capsulation, pseudocapsulation, and the somatic antigens of the surface of Staphylococcus aureus. Ann NY Acad Sci 128 45 56
4. ProjanSJ
NesinM
DunmanPM
2006 Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Curr Opin Pharmacol 6 473 479
5. ChengAG
KimHK
BurtsML
KrauszT
SchneewindO
2009 Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23 1 12
6. MazmanianSK
SkaarEP
GasparAH
HumayunM
GornickiP
2003 Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299 906 909
7. ThammavongsaV
KernJW
MissiakasDM
SchneewindO
2009 Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med 206 2417 2427
8. GoodyearCS
SilvermanGJ
2003 Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J Exp Med 197 1125 1139
9. Stranger-JonesYK
BaeT
SchneewindO
2006 Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Nat Acad Sci USA 103 16942 16947
10. KuklinNA
ClarkDJ
SecoreS
CookJ
CopeLD
2006 A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 74 2215 2223
11. KimHK
ChengAG
KimH-Y
MissiakasDM
SchneewindO
2010 Non-toxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections. J Exp Med under review
12. MuchH
1908 Über eine Vorstufe des Fibrinfermentes in Kulturen von Staphylokokkus aureus. Biochem Z 14 143
13. LoebL
1903 The influence of certain bacteria on the coagulation of blood. J Med Res 10 407
14. FieldHI
SmithHW
1945 Coagulase test for staphylococci. J Comp Pathol 55 63
15. SmithW
HaleJH
SmithMM
1947 The role of coagulase in staphylococcal infections. Brit J Exp Pathol 28 57
16. PhonimdaengP
O'ReillyM
NowlanP
BramleyAJ
FosterTJ
1990 The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol 4 393 404
17. KinoshitaM
KobayashiN
NagashimaS
IshinoM
OtokozawaS
2008 Diversity of staphylocoagulase and identification of novel variants of staphylocoagulase gene in Staphylococcus aureus. Microbiol Immunols 52 334 348
18. DuthieES
LorenzLL
1952 Staphylococcal coagulase: mode of action and antigenicity. J Gen Microbiol 6 95 107
19. PanizziP
FriedrichR
Fuentes-PriorP
RichterK
BockPE
2006 Fibrinogen substrate recognition by staphylocoagulase (pro)thrombin complexes. J Biol Chem 281 1179 1187
20. FriedrichR
PanizziP
Fuentes-PriorP
RichterK
VerhammeI
2003 Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 425 535 539
21. TagerM
DrummondMC
1965 Staphylocoagulase. Ann NY Acad Sci 128 92 111
22. BjerketorpJ
NilssonM
LjunghA
FlockJI
JacobssonK
2002 A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology 148 2037 2044
23. BjerketorpJ
JacobssonK
FrykbergL
2004 The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett 234 309 314
24. KrohHK
PanizziP
BockPE
2009 von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc Natl Acad Sci USA 106 7786 7791
25. BabaT
BaeT
SchneewindO
TakeuchiF
HiramatsuK
2007 Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes. J Bacteriol 190 300 310
26. AlbusA
ArbeitRD
LeeJC
1991 Virulence studies of Staphylococcus aureus mutants altered in type 5 capsule production. Infect Immun 59 1008 1014
27. RothforkJM
Dessus-BabusS
van WamelWJB
CheungAL
GreshamH
2003 Fibrinogen depletion attenuates Staphylococcus aureus infection by preventing density-dependent virulence gene up-regulation. J Immunol 171 5389 5395
28. SilbermanS
BernikM
OPotterE
KwuanHC
1973 Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity. Br J Haematol 24 101 113
29. BaeT
SchneewindO
2005 Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55 58 63
30. SchneewindO
Mihaylova-PetkovD
ModelP
1993 Cell wall sorting signals in surface protein of Gram-positive bacteria. EMBO 12 4803 4811
31. SchneewindO
ModelP
FischettiVA
1992 Sorting of protein A to the staphylococcal cell wall. Cell 70 267 281
32. HarveyRP
DegryseE
StefaniL
SchamberF
CazenaveJP
1986 Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci USA 83 1084 1088
33. MarkwardtF
1955 Untersuchungen über Hirudin. Naturwissenschaften 41 537 538
34. KlevensRM
MorrisonMA
NadleJ
PetitS
GershmanK
2007 Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298 1763 1771
35. DeBordKL
AndersonDM
MarketonMM
OverheimKA
DePaoloRW
2006 Immunogenicity and protective immunity against bubonic and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 74 4910 4914
36. PanizziP
FriedrichR
Fuentes-PriorP
RichterK
BockPE
2006 Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes. J Biol Chem 281 1179 1187
37. KennedyAD
OttoM
BraughtonKR
WhitneyAR
ChenL
2008 Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 105 1327 1332
38. EkstedtRD
YotisWD
1960 Effect if coagulase on the virulence of coagulase-negative strains. Ann NY Acad Sci 80 496 500
39. MoreillonP
EntenzaJM
FrancioliP
McDevittD
FosterTJ
1995 Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63 4738 4743
40. MainieroM
GoerkeC
GeigerT
GonserC
HerbertS
2010 Differential target gene activation by the Staphylococcus aureus two-component system saeRS. J Bacteriol 192 613 623
41. Birch-HirschfeldL
1934 Über die Agglutination von Staphylokokken durch Bestandteile des Säugetierblutplasmas. Klinische Woschenschrift 13 331
42. McDevittD
FrancoisP
VaudauxP
FosterTJ
1994 Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 11 237 248
43. Ní EidhinD
PerkinsS
FrancoisP
VaudauxP
HöökM
1998 Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol 30 245 257
44. GeogheganJA
GaneshVK
SmedsE
LiangX
HookM
2010 Molecular characterization of the interaction of staphylococcal MSCRAMMS ClfA and Fbl with fibrinogen. J Biol Chem Epub ahead of print
45. PalmqvistN
JosefssonE
TarkowskiA
2004 Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletion. Microbes Infect 6 196 201
46. JosefssonE
HigginsJ
FosterTJ
TarkowskiA
2008 Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One 3 e2206
47. PalmaM
WadeD
FlockM
FlockJI
1998 Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. J Biol Chem 273 13177 13181
48. HeilmannC
HerrmannM
KehrelBE
PetersG
2002 Platelet-binding domains in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J Infect Dis 186 32 39
49. HussainM
BeckerK
von EiffC
SchrenzelJ
PetersG
2001 Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol 183 6778 6786
50. WatanabeS
ItoT
SasakiT
LiS
UchiyamaI
2009 Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable virulence factors in Staphylococcus aureus. PLoS One 4 e5714
51. StreitfeldMM
SallmanB
ShoelsonSM
1959 Staphylococagulase inhibition by pooled human gamma-globulin. Nature 184 1665 1666
52. StudierFW
RosenbergAH
DunnJJ
DubendorffJW
1990 Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol 185 60 89
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia
- Dissecting the Genetic Architecture of Host–Pathogen Specificity